(-0.29%) 5 021.30 points
(0.33%) 37 940 points
(-0.39%) 15 597 points
(-3.26%) $79.26
(-2.66%) $1.938
(0.53%) $2 315.00
(0.37%) $26.75
(1.11%) $958.75
(-0.01%) $0.937
(-0.06%) $11.09
(0.09%) $0.801
(-0.48%) $93.00
1.53% $ 1.736
Live Chart Being Loaded With Signals
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States...
Stats | |
---|---|
Volumen de hoy | 23 797.00 |
Volumen promedio | 3.96M |
Capitalización de mercado | 14.78M |
EPS | $0 ( 2024-02-13 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.110 |
ATR14 | $0.00800 (0.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-25 | Duran Felipe | Buy | 35 800 | Stock Option (right to buy) |
2023-11-01 | Brenner Martin | Sell | 4 881 | Common Stock |
2023-10-03 | Brenner Martin | Sell | 5 267 | Common Stock |
2023-10-02 | Brenner Martin | Sell | 4 215 | Common Stock |
2023-08-28 | Brenner Martin | Sell | 5 011 | Common Stock |
INSIDER POWER |
---|
85.79 |
Last 90 transactions |
Buy: 50 021 245 | Sell: 29 398 433 |
Volumen Correlación
Ibio Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ibio Inc Correlación - Moneda/Commodity
Ibio Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.11M (0.00 %) |
EPS: | $-47.87 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.11M (0.00 %) |
EPS: | $-47.87 |
FY | 2022 |
Ingresos: | $2.38M |
Beneficio Bruto: | $2.17M (90.94 %) |
EPS: | $-2 924.26 |
FY | 2021 |
Ingresos: | $2.37M |
Beneficio Bruto: | $909 000 (38.34 %) |
EPS: | $-2.97 |
Financial Reports:
No articles found.
Ibio Inc
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico